Evans to speak at genomic medicine symposium on Oct. 25

The event explores the future of genomics-based therapies

Bookmark and Share
Oct. 23, 2012 – University of Houston Law Center Professor Barbara Evans will join a panel of distinguished scientists and biotechnology industry leaders to discuss the future of genomic medicine at the Chemical Heritage Foundation’s annual T. T. Chao Symposium. The meeting will be Oct. 25 from 9 a.m. – 5 p.m. at the Asia Society Texas Center in Houston. Speakers include James D. Watson, who shared the Nobel Prize in 1962 for proposing the double helical structure for DNA, as well as leading innovators in health care, systems biology, biotechnology, and genetics.

The symposium topic, “From Base Pairs to Bedside: What Happens When Genomics-Based Therapies Enter Our Clinics,” examines personalized medicine, its promise for future health care to its social ramifications and the ethical questions it raises. Evans, the co-director of the Health Law and Policy Institute at the Law Center, will discuss ownership of medical and genetic information and biospecimens, the tension between privacy and data access, and legal barriers to the commercialization of genomics-based therapies.

All sessions are free and open to the public, but registration is required. Click here for more information and to register online.

Back to Top Stories Next Story